Chronic Obstructive Pulmonary Disease Clinical Trials in Birmingham, Alabama

4 studies are recruiting for chronic obstructive pulmonary disease in Birmingham, Alabama right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

    This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COP…

    Stage
    Phase 3
    Ages
    40 to 80
    Site
    University of Alabama at Birmingham- Site Number : 8400003, Birmingham, Alabama
    Locations
    214 in total
    Run by
    Sanofi

    See if you can join NCT07190222 on ClinicalTrials.gov

  2. A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

    This study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Locations
    7 in total
    Run by
    Genentech, Inc.

    See if you can join NCT06603246 on ClinicalTrials.gov

  3. A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

    LPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is to assess the effect of dupilumab compared with placebo on airway inflammation, resistance, and remodeling including mucus plugging and its …

    Stage
    Phase 4
    Ages
    40 to 85
    Site
    University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham, Alabama
    Locations
    68 in total
    Run by
    Sanofi

    See if you can join NCT07053423 on ClinicalTrials.gov

  4. Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

    The dNerva Lung Denervation System is one-time treatment intended to improve breathing in Chronic Obstructive Pulmonary Disease (COPD) patients on standard medical care. The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System in the treatment of COPD.

    Stage
    Not phased
    Ages
    40 to 80
    Site
    University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham, Alabama
    Locations
    10 in total
    Run by
    Nuvaira, Inc.

    See if you can join NCT07051707 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.